HIV accessory genes Vif and Vpu. (Q36857081)

16 August 2017

1 reference

title

HIV accessory genes Vif and Vpu. (English)

1 reference

16 August 2017

Klaus Strebel

1

1 reference

16 August 2017

1 January 2007

1 reference

16 August 2017

Advances in Pharmacology

1 reference

16 August 2017

55

1 reference

16 August 2017

199-232

1 reference

Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

HIV-1 Vpu represents a minor target for cytotoxic T lymphocytes in HIV-1-infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Control of apoptosis by Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Vif-deficient HIV reverse transcription complexes (RTCs) are subject to structural changes and mutation of RTC-associated reverse transcription products

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Antibody reactivity to HIV-1 Vpu in HIV-1/AIDS patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Molecular cloning and polymorphism of the human immune deficiency virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

HIV-1 encoded virus protein U (Vpu) solution structure of the 41-62 hydrophilic region containing the phosphorylated sites Ser52 and Ser56.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Effects of Vpu expression on Xenopus oocyte membrane conductance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Identification of a protein encoded by the vpu gene of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Cell-free transmission of Vif mutants of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Solution structure of the cytoplasmic domain of the human immunodeficiency virus type 1 encoded virus protein U (Vpu).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The sor gene of HIV-1 is required for efficient virus transmission in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Apparent lack of trans-dominant negative effects of various vif mutants on the replication of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

HIV/HTLV gene nomenclature.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 1 Vpu has a CD4- and an envelope glycoprotein-independent function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Vpu-mediated CD4 down-regulation and degradation is conserved among highly divergent SIV(cpz) strains

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Subcellular localization of the Vif protein of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Stable, detyrosinated microtubules function to localize vimentin intermediate filaments in fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Membrane interactions and alignment of structures within the HIV-1 Vpu cytoplasmic domain: effect of phosphorylation of serines 52 and 56

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Cooperative and Specific Binding of Vif to the 5′ Region of HIV-1 Genomic RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Protein degradation or regulation: Ub the judge

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Role of vif during packing of the core of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIVTM) that is less pathogenic for pig-tailed macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Genetic organization of a chimpanzee lentivirus related to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Functional characterization and NMR spectroscopy on full-length Vpu from HIV-1 prepared by total chemical synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

vpu transmembrane peptide structure obtained by site-specific fourier transform infrared dichroism and global molecular dynamics searching

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Full length Vpu from HIV-1: combining molecular dynamics simulations with NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Presence of Intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A zinc-binding region in Vif binds Cul5 and determines cullin selection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The ancient regulatory-protein family of WD-repeat proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Conservation of amino-acid sequence motifs in lentivirus Vif proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Tilt angle of a trans-membrane helix is determined by hydrophobic mismatch

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Three-dimensional Structure of the Channel-forming Trans-membrane Domain of Virus Protein “u” (Vpu) from HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Phosphorylation of both phosphoacceptor sites in the HIV-1 Vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Isolation and characterization of HIV-2ben obtained from a patient with predominantly neurological defects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The Antibody Response to the HIV-1 Specific "Out" (vpu) Protein: Identification of an Immunodominant Epitope and Correlation of Antibody Detectability to Clinical Stages

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is rev-dependent and regulated by splicing

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Structure and dynamics of the HIV-1 Vpu transmembrane domain revealed by solid-state NMR with magic-angle spinning

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Evidence for a newly discovered cellular anti-HIV-1 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Mutational analysis of the human immunodeficiency virus type 1 Vif protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The presence of the casein kinase II phosphorylation sites of Vpu enhances the CD4(+) T cell loss caused by the simian-human immunodeficiency virus SHIV(KU-lbMC33) in pig-tailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The redox state of cysteines in human immunodeficiency virus type 1 Vif in infected cells and in virions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Saccharomyces cerevisiae cdc15 mutants arrested at a late stage in anaphase are rescued by Xenopus cDNAs encoding N-ras or a protein with beta-transducin repeats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The HIV 'A' (sor) gene product is essential for virus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A novel gene of HIV-1, vpu, and its 16-kilodalton product

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Functional role of human immunodeficiency virus type 1 vpu.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Secondary structure and tertiary fold of the human immunodeficiency virus protein U (Vpu) cytoplasmic domain in solution

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and lH NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Phosphorylation of Vif and its role in HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Identification of the receptor component of the IkappaBalpha-ubiquitin ligase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

Comparative structural studies of Vpu peptides in phospholipid monolayers by x-ray scattering.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955006-4

7 January 2021

10.1016/S1054-3589(07)55006-4

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17586316